STRATA Skin Sciences, Inc. (SSKN) — Institutional Holders, Q4 2025
14 institutional investment managers reported a SSKN position on SEC Form 13F-HR for the quarter ended December 31, 2025, with a combined reported value of $1.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SSKN in Q4 2025: what funds did
Funds that filed a 13F for both Q3 2025 and Q4 2025, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Apollon Wealth ManagementNew · +15,105 sh+$19.0K
- TWO SIGMA SECURITIESNew · +15,093 sh+$19.0K
- Tower Research Capital (TRC)Added · +2,463 sh+$3.1K
- GEODE CAPITAL MANAGEMENTAdded · +759 sh+$956.00
- UBS Group AGAdded · +691 sh+$871.00
Biggest sellers
- RENAISSANCE TECHNOLOGIESTrimmed · -37,700 sh-$47.5K
- AZZAD ASSET MANAGEMENTSold out · -21,800 sh-$27.5K
- MGO ONE SEVENSold out · -17,142 sh-$21.6K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -12,426 sh-$15.7K
- VANGUARD GROUPTrimmed · -7,170 sh-$9.0K
SSKN 13F holders ranked 1–14 of 14
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q3 2025 |
|---|---|---|---|---|---|
| 1 | 22NW#1 · 536,995 sh | 536,995 | $676.6K | — | 0.0% |
| 2 | Nantahala Capital Management#2 · 403,917 sh | 403,917 | $508.9K | — | 0.0% |
| 3 | RENAISSANCE TECHNOLOGIES#3 · 63,830 sh | 63,830 | $80.4K | — | -37.1% |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 18,896 sh | 18,896 | $23.8K | — | +4.2% |
| 5 | VANGUARD GROUP#5 · 16,375 sh | 16,375 | $20.6K | 0.00% | -30.5% |
| 6 | Apollon Wealth Management#6 · 15,105 sh | 15,105 | $19.0K | — | New |
| 7 | TWO SIGMA SECURITIES#7 · 15,093 sh | 15,093 | $19.0K | — | New |
| 8 | Creative Planning#8 · 10,016 sh | 10,016 | $12.6K | — | 0.0% |
| 9 | BlackRock#9 · 4,465 sh | 4,465 | $5.6K | — | 0.0% |
| 10 | Tower Research Capital (TRC)#10 · 4,292 sh | 4,292 | $5.4K | — | +134.7% |
| 11 | UBS Group AG#11 · 1,061 sh | 1,061 | $1.3K | — | +186.8% |
| 12 | Financial Perspectives#12 · 101 sh | 101 | $127.00 | — | 0.0% |
| 13 | BANK OF AMERICA#13 · 92 sh | 92 | $116.00 | — | -52.3% |
| 14 | Allworth Financial#14 · 5 sh | 5 | $7.00 | — | 0.0% |
Funds that sold out of SSKN in Q4 2025 (5)
Held SSKN at the end of Q3 2025 and filed a Q4 2025 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q3 2025 |
|---|---|---|
| AZZAD ASSET MANAGEMENT21,800 sh | 21,800 | $44.9K |
| MGO ONE SEVEN17,142 sh | 17,142 | $35.3K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP12,426 sh | 12,426 | $25.6K |
| SBI Securities , Ltd.2 sh | 2 | $4.00 |
| MORGAN STANLEY1 sh | 1 | $2.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q4 2025. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q3 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.